The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 334:399-400 February 8, 1996 Number 6
NextNext

Methotrexate and Misoprostol to Terminate Early Pregnancy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by El-Refaey, H.
-Related Article
by Hausknecht, R. U.
To the Editor: The article by Hausknecht on the use of methotrexate and misoprostol to terminate early pregnancy (Aug. 31 issue)1 and the earlier article by El-Refaey et al. on the induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol (April 13 issue)2 demonstrate the efficacy of medically supervised treatment with oral and vaginal abortifacients as an alternative to surgical therapy. However, with the increasing publicity given to the use of these agents for other medical indications, young women with unwanted pregnancies may turn to these drugs without medical supervision.

Since antiquity, folk remedies have been described . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.